Document is current
Any future updates will be listed below
-
Authors
Shoumariyeh, Khalid
Jung, Johannes
Rassner, Michael
Dold, Sandra Maria
Riebl, Veronika
Pantic, Milena
Herget, Georg
Marks, Reinhard
Lübbert, Michael
Wäsch, Ralph
Engelhardt, Monika https://orcid.org/0000-0003-0405-1676
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (1095969, 111424)
Else Kröner-Fresenius-Stiftung
- License Information
-
More Information
Article History
Received: 15 February 2021
Accepted: 2 March 2021
First Online: 13 March 2021
Declarations
:
: Informed consent was obtained from the patient for being included in this study.
: JJ, MR, SMD, VR, MP, GH, RM, ML have no financial or other relationships that might lead to a conflict of interest. KS has received travel support from Abbvie and consultancy fees from Novartis. RW has received research and travel support from Sanofi, Gilead, Jazz, Celgene, and Amgen and has received consultancy fees from Sanofi, Pfizer, Gilead, Novartis, Amgen, and Takeda. ME has received educational and trial support from Amgen, Takeda, BMS, Janssen, and Novartis, in all unrelated to this case.
